Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Mallinckrodt
McKesson
Fish and Richardson
Queensland Health
Dow
Argus Health
Accenture

Generated: May 27, 2018

DrugPatentWatch Database Preview

GAVISCON Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Gaviscon, and what generic alternatives are available?

Gaviscon is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in GAVISCON is aluminum hydroxide; magnesium trisilicate. There are one hundred and thirty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aluminum hydroxide; magnesium trisilicate profile page.
Summary for GAVISCON
Drug patent expirations by year for GAVISCON

US Patents and Regulatory Information for GAVISCON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us GAVISCON aluminum hydroxide; magnesium trisilicate TABLET, CHEWABLE;ORAL 018685-001 Dec 9, 1983 OTC Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us GAVISCON aluminum hydroxide; magnesium trisilicate TABLET, CHEWABLE;ORAL 018685-002 Dec 9, 1983 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chubb
US Army
Covington
Federal Trade Commission
Accenture
Mallinckrodt
Deloitte
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.